Geoffrey Michael Glass insider trades: Avadel Pharmaceuticals (AVDL) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Geoffrey reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 10, 2024 | AVDL | ↑ Buy | 20,279 | $9.84 | $200K | By Trust | Dec 10, 2024 (0d) |
| Aug 10, 2023 | AVDL | ↑ Buy | 14,000 | $13.40 | $188K | By Trust | Aug 11, 2023 (1d) |
| Jun 1, 2022 | AVDL | ↑ Buy | 45,000 | $2.14 | $96K | By Trust | Jun 2, 2022 (1d) |
| Aug 28, 2020 | AVDL | ↑ Buy | 4,800 | $6.78 | $33K | Direct | Sep 1, 2020 (4d) |
| Aug 13, 2020 | AVDL | ↑ Buy | 13,000 | $7.73 | $100K | Direct | Aug 14, 2020 (1d) |
| Nov 18, 2019 | AVDL | ↑ Buy | 20,000 | $4.99 | $100K | Direct | Nov 19, 2019 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other AVDL insiders
Open-market trades in the last 12 months
About Geoffrey Michael Glass's insider trades
Geoffrey Michael Glass is a director at Avadel Pharmaceuticals (AVDL). Since Nov 18, 2019, Geoffrey has reported 6 open-market purchases worth $716K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (10 filings), gifts (6 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AVDL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.